Abstract:Background: Liver is an organ that could either be involved by widespread lymphoma or rarely as a primary site of lymphoma. Although secondary involvement of liver by lymphoma is relatively common, primary hepatic lymphoma (PHL) represents only about 0.016% of all cases of non-Hodgkin lymphoma. Understanding the clinicopathological features of hepatic lymphoma would direct appropriate treatment and patient management.Methods: We did a retrospective cohort study of 19 patients with liver biopsy-proven lymphoma, either as part of a systemic lymphoma or as a primary lesion, who were evaluated and treated at Harbor-UCLA Medical Center between 2004 and 2014.Results: The 19 cases were divided into two groups. Nine of them showing systemic involvement including not only liver but also spleen and/or lymph nodes were grouped together. The other 10 cases which showed confined liver lesions without involvement of other lymphoid structures were grouped in the PHL group. Clinical features of the two groups were compared. Our study demonstrated that PHL most commonly affected middle-aged individuals (median age: 50 years), with a male-to-female ratio of about 2.3 to 1. The most frequent presenting symptom was right upper quadrant pain. In contrast, the group with systemic lymphoma involving liver most commonly affected younger patients (median age: 40 years), with a male-to-female ratio of about 8 to 1, and with abdominal pain as well as fever/chills as the most common presenting symptoms. The tumor burden at the presentation as suggested by serum lactate dehydrogenase (LDH) level was statistically significantly lower in the PHL group compared to the systemic group in this study (p < 0.05). Viral infections were found in both groups, and we did not observe a clear association of any particular viral infection with PHL. Diffuse large B-cell lymphoma was identified as the major type of primary hepatic lymphoma (8 of 10 cases). Finally, the prognosis in the PHL group demonstrated by the duration of follow-up (average follow up: 50 months) was statistically significantly better than that in the systemic group (average follow up: 5.5 months), p < 0.01.Conclusion: Patients with PHL showed different clinicopathological features from those with widespread lymphoma involving liver. The outcome of the patients with PHL appeared much more favorable than that of the patients with liver involvement by systemic lymphoma in this study. Published by Elsevier Inc.

[Clinical Analysis of Liver Non-Hodgkin's Lymphoma].

[Clinical Analysis of 135 Newly Diagnosed Patients with Hodgkin Lymphoma].

A survival of 103 cases of T-cell non-Hodgkin lymphoma]

[Clinical Characteristics,Treatment Strategies and Prognostic Factors of 254 Cases of Non Hodgkin's Lymphoma].

Clinical Characteristics and Treatment of Primary Hepatic Lymphoma

Primary liver cancer complicated with non-Hodgkin’s lymphoma：two cases analysis and literature review

Clinical management and susceptibility of primary hepatic lymphoma: A cases-based retrospective study

Clinical analysis of fatty liver caused by non-Hodgkin lymphoma chemotherapy

Lymphoma of the Liver: Clinicopathological Features of 19 Patients

Primary Laryngeal Non-Hodgkin Lymphoma: a Clinical Analysis of 24 Cases

Clinicopathologic Features and Treatment Outcome of Primary Intestinal Non-Hodgkin Lymphoma: A Single Center Experience.

Diagnosis and treatment of primary hepatic lymphoma

[An Analysis of the Clinical and Laboratory Data of 53 Cases of Non-Hodgkin's Lymphoma].

[Clinical Analysis of 59 Cases of Primary Gastric Non-Hodgkin's Lymphoma].

Clinical Analysis of 67 Cases of Primary Small Intestinal Non-Hodgkin’s Lymphoma

[Prognosis Analysis of 53 Cases with Primary Intestinal Non-Hodgkin's Lymphoma].

Retrospective analysis of 91 patients with T cell non-Hodgkin's lymphoma

Primary testicular non-Hodgkin's lymphoma: clinical analysis of 21 cases]

[The Clinical and Pathological Characteristics of 14 Patients' Nodular Lymphocyte Predominant Hodgkin's Lymphoma].

[Clinical and Prognostic Analysis of 101 Cases of Primary Gastrointestinal Non-Hodgkin's Lymphoma].

[Survival Outcomes of T-cell Non-Hodgkin's Lymphoma: a Report of 111 Cases].